RJFSA
BEAT

Raymond James Financial Services Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26,282
Closed -$1.89M – 3319
2020
Q4 		$1.89M Sell
26,282
-2,946
-10% -$154K ﹤0.01% 1330
2020
Q3 		$1.33M Sell
29,228
-1,250
-4% -$52.3K ﹤0.01% 1378
2020
Q2 		$1.38M Sell
30,478
-2,416
-7% -$108K ﹤0.01% 1309
2020
Q1 		$1.27M Sell
32,894
-4,069
-11% -$187K 0.01% 1096
2019
Q4 		$1.71M Sell
36,963
-346
-0.9% -$15K 0.01% 1239
2019
Q3 		$1.52M Sell
37,309
-12,237
-25% -$528K 0.01% 1245
2019
Q2 		$2.39M Sell
49,546
-34,966
-41% -$1.84M 0.01% 1007
2019
Q1 		$5.29M Buy
84,512
+20,984
+33% +$1.44M 0.02% 634
2018
Q4 		$3.79M Sell
63,528
-36,213
-36% -$2.17M 0.02% 632
2018
Q3 		$6.43M Buy
99,741
+35,989
+56% +$2.01M 0.03% 552
2018
Q2 		$2.87M Sell
63,752
-1,240
-2% -$49.4K 0.01% 843
2018
Q1 		$2.02M Buy
64,992
+35,558
+121% +$1.17M 0.01% 925
2017
Q4 		$880K Buy
29,434
+18,945
+181% +$549K 0.01% 1377
2017
Q3 		$346K Buy
10,489
+4,157
+66% +$144K ﹤0.01% 1943
2017
Q2 		$212K Buy
+6,332
New +$189K ﹤0.01% 2190

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Raymond James Financial Services Advisors's BEAT Position: Q1 2021 in Review

Raymond James Financial Services Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 26,282 shares — an estimated $1.89M sold.

Raymond James Financial Services Advisors first reported a position in BEAT in Q2 2017 and held it in 15 quarters. The position peaked at $6.43M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Raymond James Financial Services Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 26,282 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.89M.
  • Raymond James Financial Services Advisors first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 15 quarters.
  • Raymond James Financial Services Advisors's BioTelemetry, Inc. position peaked at $6.43M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2021, filed 14 May 2021.